Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The ÃÛÌÒ´«Ã½s Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

7 Multibagger Growth Stocks to Buy to Defy the Downtrend

By Omor Ibne Ehsan
These growth stocks have explosive upside potential that could help your portfolio soar even in a challenging market environment.

7 Safe Haven Stocks That Can Withstand the ÃÛÌÒ´«Ã½’s Worst Meltdowns

By Yiannis Zourmpanos, InvestorPlace Contributor
Safe haven stocks offer stability even during market fall in communication, financials, healthcare, energy and consumer staples.

Stock ÃÛÌÒ´«Ã½ Crash Warning: Don’t Get Caught Holding These 3 Biotech Stocks

By Muslim Farooque, InvestorPlace Contributor
As the stock market corrects, focusing on stable investments is crucial. This is why you should steer clear of these biotech stocks to avoid.

AGBA Stock Pops 35% on Triller Merger Update

By William White, InvestorPlace Writer
AGBA Group stock is gaining on Tuesday as investors celebrate an update on the company's $4 billion merger with Triller.

Why Is Akili (AKLI) Stock Up 68% Today?

By William White, InvestorPlace Writer
Akili stock is taking off on Tuesday as AKLI investors celebrate $5 million of its debt being forgiven alongside a $10.5 million payment.

Stock ÃÛÌÒ´«Ã½ Crash Warning: Don’t Get Caught Holding These 3 Healthcare Stocks

By Andy Kim, InvestorPlace Contributor
These are the list of healthcare stocks to avoid that present challenges indicating signs of a crash in the near future.

Why Is Cyclacel Pharmaceuticals (CYCC) Stock Up 46% Today?

By William White, InvestorPlace Writer
Cyclacel Pharmaceuticals stock is up on Tuesday with heavy trading of CYCC shares after the company withdrew a public offering.

Slump Survivors: 3 Stocks That Will Outlast the S&P 500 Downturn

By Yiannis Zourmpanos, InvestorPlace Contributor
Discover how these stocks may progress in consumer staples, health care, and tech sectors and outperform the S&P 500.

3 Dirt-Cheap Health Stocks to Buy on Weakness

By Joey Frenette, InvestorPlace Contributor
The managed care stocks look far too cheap for investors seeking health exposure at a relatively low price of admission.

7 Defensive Stocks Built to Withstand the ÃÛÌÒ´«Ã½’s Worst Storms

By Josh Enomoto, InvestorPlace Contributor
While the equities sector experienced a bump higher for the week ending April 26, potential headwinds incentivize the case for defensive stocks to buy. First…

Is a Giant Short Squeeze in Ginkgo Bioworks (DNA) Stock?

By Shrey Dua, InvestorPlace Senior Financial News Reporter
DNA stock is up 15% today for little reason, fueling speculation that Ginkgo Bioworks may be in the midst of a short squeeze.

Why Is Deciphera Pharmaceuticals (DCPH) Stock Up 72% Today?

By William White, InvestorPlace Writer
Deciphera Pharmaceuticals stock is up on Monday after DCPH investors learned of a $2.4 billion acquisition deal with ONO Pharmaceutical.

Why Is Koninklijke Philips (PHG) Stock Up 41% Today?

By William White, InvestorPlace Writer
Koninklijke Philips stock is up on Monday as investors in PHG react to the company reaching a $1.1 billion lawsuit settlement.

3 Dividend Stocks to Buy on the Dip: April 2024

By Josh Enomoto, InvestorPlace Contributor
At first glance, the concept of dividend stocks to buy on the dip might clash with your instincts. Right now, the combination of robust employment…

The Top 3 Biotech Stocks to Buy in April 2024

By Joel Lim, InvestorPlace Contributor
Learn about the top three biotech stocks to take advantage of these companies' promising futures and pharmaceutical advances.

3 Cannabis Stocks to Buy Ahead of Florida’s Legalization Vote

By Philippa Main, InvestorPlace Contributor
Cannabis stocks have the opportunity to grow higher if Florida passes Amendment 3 in November. These three companies could benefit the most.

The Top 3 Cannabis Stocks to Buy in April 2024

By Mohammed Saqib, InvestorPlace Contributor
These cannabis stocks are well-positioned to benefit from growth of the cannabis market and provide investors with great returns in April.

Generational Wealth Builders: 3 Stocks to Own for Decades of Gains

By Stavros Tousios, InvestorPlace Contributor
These three long-term stocks to buy promise decades of gains and are poised to enhance your generational wealth.

Why Is Biodexa (BDRX) Up 70% Today?

By Josh Enomoto, InvestorPlace Contributor
Oncology specialist Biodexa inked a compelling licensing deal to treat a serious disease, and BDRX stock popped sharply higher.
Load More Articles